Crescent Biopharma Inc.

NASDAQ: CBIO · Real-Time Price · USD
13.89
-0.04 (-0.29%)
At close: Aug 15, 2025, 3:59 PM
14.06
1.19%
After-hours: Aug 15, 2025, 07:27 PM EDT

Crescent Biopharma Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2022 Dec 31, 2021
PE Ratio
0.48 -2.02 -0.08
PEG Ratio
n/a 0.02 0.08
PS Ratio
0.13 20.96 1.00
PB Ratio
-0.88 -0.77 0.18
P/FCF Ratio
-2.29 -0.5 -0.09
P/OCF Ratio
-3.74 -0.5 -0.09
OCF/S Ratio
-0.03 -41.68 -11.41
Debt / Equity Ratio
-0.1 -0.00 0.06
Quick Ratio
2.99 1.68 3.63
Current Ratio
3.32 1.68 3.63
Asset Turnover
2.97 0.03 0.13
Interest Coverage
n/a -12.01 n/a
Return on Equity
-1.84 0.38 -2.14
Return on Assets
0.80 -0.29 -1.58
Return on Invested Capital
0.19 -0.77 -2.02
Dividend Yield
n/a 2.71 n/a
Payout Ratio
n/a -5.46 n/a
Gross Profit Margin
0.96 -0.01 -0.01
Net Profit Margin
0.27 -10.38 -11.98
Pretax Profit Margin
0.22 -9.94 -11.98
Operating Profit Margin
0.15 -10.85 -11.98
FCF Margin
n/a n/a n/a
EBITDA Margin
0.15 -65.68 -11.94